Recent Analyst Forecasts and Stock Ratings
CRISPR Therapeutics AG FAQ's
CRISPR Therapeutics AG has been rated by research analysts at UBS, Morgan Stanley, Bernstein, Evercore ISI, Chardan Capital, Needham in the past 90 days.
CRISPR Therapeutics AG has been rated by research analysts at UBS, Morgan Stanley, Bernstein, Evercore ISI, Chardan Capital, Needham in the past 90 days.